Intracranial Arterial Stenosis beyond Atherosclerosis: Insights from RNF213
Journal of Atherosclerosis and Thrombosis · 2026
DOI: 10.5551/jat.rv22053 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2026. Verfasst von Shuhei Okazaki. Beteiligte Einrichtung: Department of Neurology, National Hospital Organization Osaka National Hospital. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Atherosclerosis, Adenosine Triphosphatases, Intracranial Arterial Diseases. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Intracranial arterial stenosis is a major cause of ischemic stroke worldwide, particularly in the Asian population. Although traditionally regarded as a manifestation of atherosclerotic disease, increasing evidence suggests that non-atherosclerotic arteriopathies also contribute substantially to its pathogenesis. These conditions, including arterial dissection, inflammatory vasculopathies, and moyamoya disease, often share overlapping clinical and imaging features, thus making precise differentiation challenging in routine practice.This phenotypic overlap highlights the heterogeneity of intracranial arterial stenosis and suggests that it may represent a spectrum of vascular disorders, rather than a single disease entity. Recent studies have highlighted the role of genetic susceptibility as a factor underlying this diversity. Among these, RNF213, originally identified as a susceptibility gene for moyamoya disease, has been implicated in a subset of intracranial arterial diseases beyond the classical diagnostic categories. These observations have led to the concept of RNF213-related vasculopathy, which extends beyond intracranial circulation and provides a framework for understanding diverse vascular phenotypes within a broader context. In addition, a two-hit model has been proposed in which genetic susceptibility interacts with environmental and acquired factors to influence the disease onset and progression.This narrative review summarizes the current understanding of intracranial arterial stenosis beyond the conventional atherosclerosis-centered paradigm and discusses emerging concepts integrating vascular heterogeneity, genetic susceptibility, and environmental modifiers with potential implications for disease classification and individualized therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, National Hospital Organization Osaka National Hospital.
- Department of Neurology, The University of Osaka Graduate School of Medicine.
Zitieren
APA
Okazaki, S. (2026). Intracranial Arterial Stenosis beyond Atherosclerosis: Insights from RNF213. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.rv22053
Vancouver
Okazaki S. Intracranial Arterial Stenosis beyond Atherosclerosis: Insights from RNF213. Journal of Atherosclerosis and Thrombosis. 2026. doi:10.5551/jat.rv22053
BibTeX
@article{Okazaki2026,
author = {Okazaki, Shuhei},
title = {Intracranial Arterial Stenosis beyond Atherosclerosis: Insights from RNF213},
journal = {Journal of Atherosclerosis and Thrombosis},
year = {2026},
doi = {10.5551/jat.rv22053}
}
EUVIMED